SFT Thijsen et al. Hypersensitivity of bcr-abl progenitors to hyperthermia in patients with chronic myeloid leukemia. Leukemia 1997; 11: 1762-1768
Baccarani, M.
Leukemia 12(7): 1168-1170
1998
ISSN/ISBN: 0887-6924 PMID: 9665208 Document Number: 486010
Document emailed within 1 workday
Related Documents
Tomás, J.F.; Fernández-Rañada, J.M. 1995: The transplantation of hemopoietic progenitors in chronic myeloid leukemia: why, how and when? Medicina Clinica 104(17): 653-655Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Juvekar, A.S.; Chitnis, M.P.; Advani, S.H. 1987: In vitro modulation of adriamycin and mitoxantrone cytotoxicity by hyperthermia and diazepam, in human chronic myeloid leukemia cells Neoplasma 34(2): 199-204
Kane, S.B.; Advani, S.H.; Gopal, R.; Nair, C.N.; Saikia, T.K.; Kamat, D.M. 1985: Chronic myeloid leukemia blast crisis presenting with meningeal leukemia Journal of the Association of Physicians of India 33(3): 240-241
Groffen, J.; Voncken, J.W.; van Schaick, H.; Heisterkamp, N. 1992: Animal models for chronic myeloid leukemia and acute lymphoblastic leukemia Leukemia 6(Suppl 1): 44-46
Yenerel, M.N.; Hatemi, I.; Keskin, H. 1999: Concomitant chronic lymphocytic leukemia and acute myeloid leukemia diagnosed by two color flow cytometric analysis Haematologica 84(8): 766-767
Misset, J.L.; Venuat, A.M.; Nevarez, L.; Mathé, G. 1977: Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome? La Nouvelle Presse Medicale 6(27): 2409-2413
Wächter, M.; Goldschmidt, H.; Blau, W.; Elstner, E.; Ihle, R. 1988: Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro Folia Haematologica 115(6): 927-934
Atkinson, K.; Downs, K.; Ashby, M.; Dodds, A.; Concannon, A.; Biggs, J. 1989: Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia Bone Marrow Transplantation 4(1): 23-27
Tsuji-Takayama, K.; Kamiya, T.; Nakamura, S.; Matsuo, Y.; Adachi, T.; Tsubota, T.; Imanishi, J.; Minowada, J. 1994: Establishment of multiple leukemia cell lines with diverse myeloid and/or megakaryoblastoid characteristics from a single Ph1 positive chronic myelogenous leukemia blood sample Human Cell 7(3): 167-171
Schoch, C.; Schnittger, S.; Kern, W.; Dugas, M.; Hiddemann, W.; Haferlach, T. 2003: Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia Haematologica 88(3): 351-352
Tricot, G.; Weber, G. 1996: Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity Anticancer Research 16(6a): 3341-3347
Abdulkadyrov, K.M.; Rukavitzyn, O.A.; Bessmel'tsev, S.S.; Lomtev, A.I. 1997: Effect of patients' gender on the course of chronic myeloid leukemia Voprosy Onkologii 43(3): 290-294
Torelli, U.; Torelli, G.; Cadossi, R.; Ferrari, S.; Ferrari, S.; Montagna, G.; Narni, F.; Franchini, G.; Donelli, A. 1978: The primary product of DNA transcription in the blast cell of acute leukemia. its characterization as an approach to the understanding of the origin of the blast crisis of chronic myeloid leukemia Bollettino dell'Istituto Sieroterapico Milanese 57(3): 325-333
Faber, E.; Jarosová, M.; Divoký, V.; Luhový, M.; Komenda, S.; Sulovská, I.; Hubácek, J.; Slezák, P.; Papajik, T.; Raida, L.; Heczko, M.; Indrák, K. 1997: Interferon-alpha in the treatment of patients with chronic myeloid leukemia Vnitrni Lekarstvi 43(1): 13-17
DeAngelo, D.J. 2014: Switching drugs midstream for patients with chronic myeloid leukemia Clinical Advances in Hematology and Oncology: H&o 12(7): 466-468
Shen, J.-k.; Zhang, G.-s.; Xiao, L. 2003: Analysis of cytogenetic features in the patients with chronic myeloid leukemia Hunan Yi Ke da Xue Xue Bao 28(4): 431-432
Mahon, F.-X. 2019: When can tyrosine kinase inhibitors be discontinued in patients with chronic myeloid leukemia? Clinical Advances in Hematology and Oncology: H&o 17(2): 101-103
Mendeleev, I.M.; Berliner, G.B.; Miasnikov, A.A.; Polezheav, I.N. 1986: Results of splenectomy with polychemotherapy in the treatment of 15 chronic myeloid leukemia patients Terapevticheskii Arkhiv 58(9): 84-88